230 related articles for article (PubMed ID: 34742016)
1. Therapeutic potential of quinazoline derivatives for Alzheimer's disease: A comprehensive review.
Haghighijoo Z; Zamani L; Moosavi F; Emami S
Eur J Med Chem; 2022 Jan; 227():113949. PubMed ID: 34742016
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease.
Manzoor S; Gabr MT; Rasool B; Pal K; Hoda N
Bioorg Chem; 2021 Nov; 116():105354. PubMed ID: 34562674
[TBL] [Abstract][Full Text] [Related]
3. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
Weinreb O; Amit T; Bar-Am O; Youdim MB
Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830
[TBL] [Abstract][Full Text] [Related]
5. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation.
Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L
Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents.
Ye C; Xu R; Cao Z; Song Q; Yu G; Shi Y; Liu Z; Liu X; Deng Y
Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586
[TBL] [Abstract][Full Text] [Related]
7. New flavonoid -
Estrada-Valencia M; Herrera-Arozamena C; Pérez C; Viña D; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Laurini E; Pricl S; Rodríguez-Franco MI
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):712-727. PubMed ID: 31852270
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present).
Wang N; Qiu P; Cui W; Yan X; Zhang B; He S
Curr Med Chem; 2019; 26(30):5684-5710. PubMed ID: 30501591
[TBL] [Abstract][Full Text] [Related]
9. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
Khalid S; Zahid MA; Ali H; Kim YS; Khan S
BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
11. Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.
Guzior N; Wieckowska A; Panek D; Malawska B
Curr Med Chem; 2015; 22(3):373-404. PubMed ID: 25386820
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease.
Shukur KT; Ercetin T; Luise C; Sippl W; Sirkecioglu O; Ulgen M; Coskun GP; Yarim M; Gazi M; Gulcan HO
Arch Pharm (Weinheim); 2021 May; 354(5):e2000467. PubMed ID: 33511649
[TBL] [Abstract][Full Text] [Related]
13. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy.
Zagórska A; Jaromin A
Molecules; 2020 Jul; 25(15):. PubMed ID: 32717806
[TBL] [Abstract][Full Text] [Related]
14. An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review.
Karim N; Khan H; Khan I; Guo O; Sobarzo-Sánchez E; Rastrelli L; Kamal MA
Med Chem; 2020; 16(8):1007-1021. PubMed ID: 31702507
[TBL] [Abstract][Full Text] [Related]
15. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.
Kim J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772
[TBL] [Abstract][Full Text] [Related]
16. Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.
Lin LF; Luo HM
Neurosci Bull; 2011 Feb; 27(1):53-60. PubMed ID: 21270904
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
[TBL] [Abstract][Full Text] [Related]
19. Fused thiophene as a privileged scaffold: A review on anti-Alzheimer's disease potentials via targeting cholinesterases, monoamine oxidases, glycogen synthase kinase-3, and Aβ aggregation.
Kassab AE; Gedawy EM; Sayed AS
Int J Biol Macromol; 2024 Apr; 265(Pt 2):131018. PubMed ID: 38518928
[TBL] [Abstract][Full Text] [Related]
20. Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
Ali M; Saleem U; Anwar F; Imran M; Nadeem H; Ahmad B; Ali T; Atta-Ur-Rehman ; Ismail T
Neurochem Res; 2021 Apr; 46(4):905-920. PubMed ID: 33486698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
